Enhancing Healthcare Access: Prior Authorization and External Review Processes

Initially designed to control healthcare costs, prior authorization has increasingly hampered access to necessary healthcare services. On April 3, the Pennsylvania Insurance Department introduced an external review process, providing consumers an option when insurers deny treatment coverage. Notably, since its 2024 implementation, the program's usage has tripled, with half of the review cases leading to overturned insurer decisions.

Despite this growth, the program processed only 1,353 cases in a state of over 13 million residents. A key barrier is the regulatory stipulation that patients must exhaust internal remedies with their insurers before seeking external reviews. While meant to reduce unnecessary appeals, this requirement often becomes a hurdle, with internal processes being complex and demanding a deep understanding of health insurance. Consequently, less than one percent of consumers appeal denied claims on health insurance exchanges.

The widespread application of prior authorization, once a tool for cost-containment, has now become a significant obstacle to equitable care access. This underscores the need for more user-friendly external review mechanisms. The history of U.S. health insurance reflects persistent cost-control efforts, with post-World War II seeing the rise of employer-sponsored insurance and the later introduction of managed healthcare plans.

Evolution of Managed Care Plans

In the 1970s, managed healthcare plans like health maintenance organizations (HMOs) and preferred provider organizations (PPOs) gained traction due to their cost-efficiency. These plans introduced prior authorization to verify medical necessity before services were rendered, aiming to curb overprescription. However, they also posed new challenges in accessing needed treatments.

In recent decades, the reach and complexity of AI-driven prior authorization have grown, impacting a wide array of medical services. This has caused delays in essential treatments, such as prescriptions and diagnostic procedures. As the healthcare system seeks balance between cost control and patient safety, prior authorization continues to be a barrier to timely care access.

Independent medical review processes seek to alleviate coverage denials, yet programs like Pennsylvania's highlight substantial hurdles in accessing external reviews. As healthcare provisions evolve, so must the appeals mechanisms, ensuring they are both effective and accessible. While oversight on healthcare provision remains crucial, consumer access to recourse should face fewer restrictions.